Metabolic interaction of isoniazid and rifampicin on cytochrome P450 1A2 and 3A4 by using replatable cryopreserved human primary hepatocytes

被引：0
|
作者：
Cai, Yingyun
Liu, Zhengwei
Fang, Sishi
Liu, Zhengwei
Hu, Zhuohan
Cai, Yingyun
Hu, Zhuohan
机构：
[1] Shanghai Zhongshan Hosp, Shanghai, Peoples R China
[2] Liver Dis Co Ltd, Res Inst, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai 200433, Peoples R China
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [21] Substrates of human hepatic cytochrome P450 3A4
    Li, AP
    Kaminski, DL
    Rasmussen, A
    TOXICOLOGY, 1995, 104 (1-3) : 1 - 8
  • [22] Assessment of Cytochrome P450 (1A2, 2B6, 2C9 and 3A4) Induction in Cryopreserved Human Hepatocytes Cultured in 48-well Plates Using the Cocktail Strategy
    Gerin, Brigitte
    Dell' Aiera, Sylvie
    Boekens, Hilmar
    Smith, Steven
    Chanteux, Hugues
    DRUG METABOLISM REVIEWS, 2010, 42 : 132 - 132
  • [23] Metabolic Intermediate Complex Formation of Human Cytochrome P450 3A4 by Lapatinib
    Takakusa, Hideo
    Wahlin, Michelle D.
    Zhao, Chunsheng
    Hanson, Kelsey L.
    New, Lee Sun
    Chan, Eric Chun Yong
    Nelson, Sidney D.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (06) : 1022 - 1030
  • [24] Inhibition of Human Cytochrome P450 3A4 by Cholesterol
    Shinkyo, Raku
    Guengerich, F. Peter
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (21) : 18426 - 18433
  • [25] Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine
    Williamson, Beth
    Dooley, Kelly E.
    Zhang, Yuan
    Back, David J.
    Owen, Andrew
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 6366 - 6369
  • [26] Cytochrome P450 3A4 drug interaction profile of tofacitinib
    Krishnaswami, Sriram
    Lamba, Manisha
    Gupta, Pankaj
    Takiya, Liza
    Wang, Ronnie
    Kaplan, Irina
    Salageanu, Joanne
    Tarabar, Sanela
    Alvey, Christine
    Ndongo, Marie-Noella
    PHARMACOTHERAPY, 2012, 32 (10): : E240 - E240
  • [27] Drug-drug interactions of deoxyschizandrin with Cytochrome P450 1A2,2A6,2D6, and 3A4 by using pooled human liver microsomes and primary human hepatocytes
    Cai, Xiong
    Zhao, Shuming
    Pei, Bing
    Xin, Haiguang
    Fan, Sishi
    Mao, Yuchang
    Liao, Yanping
    Hu, Zhuohan
    Hu, Zhuohan
    DRUG METABOLISM REVIEWS, 2006, 38 : 140 - 141
  • [28] Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes
    Wen, X
    Wang, JS
    Neuvonen, PJ
    Backman, JT
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 57 (11) : 799 - 804
  • [29] Oxidation of human cytochrome P450 1A2 substrates by Bacillus megaterium cytochrome P450 BM3
    Kim, Dong-Hyun
    Kim, Keon-Hee
    Kim, Dooil
    Jung, Heung-Chae
    Pan, Jae-Gu
    Chi, Youn-Tai
    Ahn, Taeho
    Yun, Chul-Ho
    JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 2010, 63 (3-4) : 179 - 187
  • [30] Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes
    Xia Wen
    Jun-Sheng Wang
    Pertti J. Neuvonen
    Janne T. Backman
    European Journal of Clinical Pharmacology, 2002, 57 : 799 - 804
12345